BioTech/Drugs - Doylestown, PA, US
OCMS Bio is a Research Tools Company. Our proprietary technology On-Cell mAb Screening (OCMS™), greatly speeds antibody discovery. OCMS™ methods transform mAb discovery from patient-derived antibodies, transgenic mouse models, and Artificial Intelligence (AI) antibody engineering. A major focus of our internal research program is AI-driven pandemic prediction.
Gmail
Apache
Mobile Friendly
YouTube